Investing.com — is getting ready to sell its orthopedics unit, DePuy Synthes, which could be valued at more than $20 billion, according to a report from Bloomberg News, citing people familiar with the matter.
The company is currently preparing documents and financial information for the unit before meeting with potential buyers in the coming weeks, these sources said.
Several large private equity firms are considering forming teams to potentially acquire the business, which specializes in devices used in hip and knee replacements. The unit generated $9.3 billion in sales last year.
Besides private equity interest, the DePuy Synthes business could also attract attention from competing medical device companies, according to the sources.
J&J had previously announced plans to separate the orthopedics unit, but is now exploring an outright sale option.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.